HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association of MEF2A gene 3'UTR mutations with coronary artery disease.

Abstract
Association of variants in the myocyte enhancer factor 2A (MEF2A) gene and the risk of coronary artery disease (CAD) has drawn much attention but remains controversial. We hypothesized that the 3'-untranslated region (3'-UTR) of this gene could harbor functionally relevant nucleotide changes. Here, we assessed the association between single nucleotide polymorphisms (SNPs) in the 3'-UTR of MEF2A and CAD in the Chinese Han population. A case-control study of 236 CAD patients and 278 controls was carried out. The four target SNPs were genotyped using a multiplex PCR-ligase detection reaction method. Logistic regression under three genetic models was used to analyze the association between target SNPs and the risk of CAD. Associations were detected between two SNPs (rs325380, rs897074) and CAD; however, after Bonferroni's correction, these associations were not deemed significant. A further haplotype study indicated that a 'TA' haplotype carrier of rs325380-rs325381 was associated with CAD risk. Our study thus indicates that variants in the 3'-UTR of MEF2A are associated with CAD in a Chinese Han population.
AuthorsX C Huang, W Wang
JournalGenetics and molecular research : GMR (Genet Mol Res) Vol. 14 Issue 3 Pg. 11073-8 (Sep 21 2015) ISSN: 1676-5680 [Electronic] Brazil
PMID26400337 (Publication Type: Journal Article)
Chemical References
  • 3' Untranslated Regions
  • MEF2 Transcription Factors
  • MEF2A protein, human
Topics
  • 3' Untranslated Regions
  • Aged
  • Case-Control Studies
  • Coronary Artery Disease (genetics)
  • Female
  • Gene Frequency
  • Genetic Association Studies
  • Genetic Predisposition to Disease
  • Haplotypes
  • Humans
  • MEF2 Transcription Factors (genetics)
  • Male
  • Middle Aged
  • Mutation
  • Polymorphism, Single Nucleotide
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: